Co-Authors
This is a "connection" page, showing publications co-authored by Chia Kow and Syed Hasan.
Connection Strength
65.782
-
Amiodarone in COVID-19: let's not forget its potential for pulmonary toxicity. Eur J Prev Cardiol. 2022 02 09; 28(18):e52.
Score: 0.995
-
Corticosteroid-related In-Hospital Hyperglycemia: Does It Negate Mortality Benefits in Coronavirus Disease 2019? Clin Infect Dis. 2021 11 02; 73(9):e2848-e2849.
Score: 0.977
-
The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2021 Aug 03.
Score: 0.960
-
Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies. Inflammopharmacology. 2021 Aug; 29(4):1075-1090.
Score: 0.955
-
Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis. 2021 07 01; 73(1):164-165.
Score: 0.954
-
Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Hypertens Res. 2021 08; 44(8):1042-1045.
Score: 0.946
-
Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK. J Infect. 2021 07; 83(1):e14-e15.
Score: 0.945
-
Cerebral Venous Thrombosis following COVID-19 Vaccination. J Stroke Cerebrovasc Dis. 2021 10; 30(10):105866.
Score: 0.944
-
Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One. Chest. 2021 05; 159(5):2108-2109.
Score: 0.943
-
Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury. Int Braz J Urol. 2021 May-Jun; 47(3):690-691.
Score: 0.943
-
The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology. 2021 Jun; 29(3):641-644.
Score: 0.941
-
Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis. J Thromb Thrombolysis. 2021 Jul; 52(1):124-129.
Score: 0.938
-
The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep. 2021 Oct; 73(5):1473-1479.
Score: 0.937
-
Do sleep quality and sleep duration before or after COVID-19 vaccination affect antibody response? Chronobiol Int. 2021 07; 38(7):941-943.
Score: 0.936
-
Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1365-1367.
Score: 0.933
-
Insulin Treatment May Not Be Associated with Increased Mortality in Patients with COVID-19 and Concurrent Diabetes. Endocr Res. 2021 Feb-May; 46(2):51-52.
Score: 0.931
-
Preadmission use of inhaled corticosteroids and risk of fatal or severe COVID-19: a meta-analysis. J Asthma. 2021 Feb 08; 1-4.
Score: 0.928
-
Potential interactions between COVID-19 vaccines and antiepileptic drugs. Seizure. 2021 03; 86:80-81.
Score: 0.928
-
The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2021 Aug; 77(8):1089-1094.
Score: 0.927
-
Interferon-based therapies in COVID-19. Int Immunopharmacol. 2021 Apr; 93:107415.
Score: 0.926
-
Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19. Rheumatol Int. 2021 03; 41(3):677-678.
Score: 0.922
-
Persistent fatigue in patients with COVID-19. Clin Med (Lond). 2021 01; 21(1):e117.
Score: 0.922
-
Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic. Obes Surg. 2021 01; 31(1):413-414.
Score: 0.922
-
Pharmacologic therapeutic options for thromboprophylaxis in COVID-19. J Thromb Thrombolysis. 2021 Jan; 51(1):29-30.
Score: 0.922
-
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19. Therapie. 2021 Jul-Aug; 76(4):361-364.
Score: 0.921
-
Optimal time for the resumption of biologics after COVID-19. JAAD Int. 2020 Dec; 1(2):189.
Score: 0.920
-
The use of combined hormonal contraceptives amid the COVID-19 pandemic. Eur J Contracept Reprod Health Care. 2021 02; 26(1):85-86.
Score: 0.916
-
Use of Pharmacologic Agents With Weight Gain Potential for Panic Disorder Amid the COVID-19 Pandemic. Prim Care Companion CNS Disord. 2020 11 25; 22(6).
Score: 0.915
-
Dexamethasone or hydrocortisone in COVID-19? Cleve Clin J Med. 2020 11 23; 87(12):715.
Score: 0.915
-
Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications. Card Fail Rev. 2020 Mar; 6:e32.
Score: 0.915
-
Use of DPP-4 inhibitors in patients with COVID-19. Acta Diabetol. 2021 02; 58(2):245-246.
Score: 0.914
-
Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic. Expert Rev Cardiovasc Ther. 2021 01; 19(1):99-100.
Score: 0.913
-
Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials. J Med Virol. 2021 04; 93(4):1860-1861.
Score: 0.913
-
Prochlorperazine for nausea and vomiting accompanied COVID-19. J Gastroenterol Hepatol. 2021 Feb; 36(2):524-525.
Score: 0.911
-
Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis. Am J Trop Med Hyg. 2020 11; 103(5):2149.
Score: 0.911
-
Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis. J Intern Med. 2021 01; 289(1):125-128.
Score: 0.909
-
Macrolides for patients with COVID-19 and concurrent pertussis infection. Diagn Microbiol Infect Dis. 2021 Feb; 99(2):115245.
Score: 0.908
-
Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease. Rheumatol Int. 2020 12; 40(12):2117-2118.
Score: 0.908
-
Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol. 2021 Mar; 77(3):435-437.
Score: 0.906
-
Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? Allergy. 2021 03; 76(3):959-960.
Score: 0.906
-
The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic. Headache. 2020 10; 60(9):2085-2086.
Score: 0.906
-
Use of Azithromycin in COVID-19: A Cautionary Tale. Clin Drug Investig. 2020 10; 40(10):989-990.
Score: 0.906
-
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis. J Med Virol. 2021 02; 93(2):695-697.
Score: 0.906
-
[Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19]. Rev Esp Cardiol. 2021 Feb; 74(2):200-201.
Score: 0.906
-
Azithromycin in patients with COVID-19: Friend or foe? Clin Microbiol Infect. 2021 01; 27(1):136-137.
Score: 0.905
-
[The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19]. Rev Esp Cardiol. 2021 Jan; 74(1):114-115.
Score: 0.904
-
The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19. Obesity (Silver Spring). 2020 11; 28(11):2035.
Score: 0.904
-
Revascularization in COVID-19 patients with renal infarction. Am J Transplant. 2021 03; 21(3):1345.
Score: 0.904
-
The use of antimotility drugs in COVID-19 associated diarrhea. J Infect. 2021 02; 82(2):e19.
Score: 0.904
-
Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19. Rev Esp Cardiol (Engl Ed). 2021 02; 74(2):200-201.
Score: 0.904
-
The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19. Rev Esp Cardiol (Engl Ed). 2021 01; 74(1):114-115.
Score: 0.900
-
Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers. Drugs Ther Perspect. 2020 Aug 16; 1-5.
Score: 0.898
-
Meta-analysis of Effect of Statins in Patients with COVID-19. Am J Cardiol. 2020 11 01; 134:153-155.
Score: 0.897
-
Montelukast in children with allergic rhinitis amid COVID-19 pandemic. Acta Paediatr. 2020 10; 109(10):2151.
Score: 0.896
-
Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic. J Formos Med Assoc. 2021 01; 120(1 Pt 3):772-773.
Score: 0.896
-
Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2020 12; 29(12):105222.
Score: 0.896
-
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide. Am J Cardiovasc Drugs. 2020 Aug; 20(4):301-309.
Score: 0.895
-
Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients. Eur J Hosp Pharm. 2021 01; 28(1):42-46.
Score: 0.895
-
Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. Expert Rev Cardiovasc Ther. 2020 Aug; 18(8):475-485.
Score: 0.894
-
Role of frailty in COVID-19 patients. Intensive Care Med. 2020 10; 46(10):1956-1957.
Score: 0.891
-
Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury. J Am Soc Nephrol. 2020 08; 31(8):1917-1918.
Score: 0.890
-
Could melatonin be used in COVID-19 patients with laryngopharyngeal reflux disease? J Med Virol. 2021 01; 93(1):92-93.
Score: 0.889
-
Use of low-molecular-weight heparin in COVID-19 patients. J Vasc Surg Venous Lymphat Disord. 2020 09; 8(5):900-901.
Score: 0.888
-
Metformin use amid coronavirus disease 2019 pandemic. J Med Virol. 2020 11; 92(11):2401-2402.
Score: 0.886
-
Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" Nutrients 2020, 12(4), 988. Nutrients. 2020 Jun 01; 12(6).
Score: 0.885
-
Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020 Jun; 20(3):217-221.
Score: 0.885
-
Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection. 2020 10; 48(5):805-806.
Score: 0.881
-
An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan. Vaccine. 2021 08 31; 39(37):5251-5253.
Score: 0.240
-
The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review. Expert Rev Anti Infect Ther. 2022 02; 20(2):211-229.
Score: 0.240
-
Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials. Expert Rev Respir Med. 2021 08; 15(8):1049-1055.
Score: 0.239
-
Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan. SN Compr Clin Med. 2021 May 28; 1-5.
Score: 0.237
-
Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru. 2021 Jun; 29(1):217-221.
Score: 0.234
-
Effect of COVID-19 on viral hepatitis services in Pakistan. Lancet Gastroenterol Hepatol. 2021 03; 6(3):163-164.
Score: 0.233
-
COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK. Expert Rev Respir Med. 2021 08; 15(8):973-978.
Score: 0.233
-
Association of frailty and mortality in patients with COVID-19: a meta-analysis. Br J Anaesth. 2021 03; 126(3):e108-e110.
Score: 0.229
-
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020 Nov; 50(4):814-821.
Score: 0.228
-
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021 Feb; 22(2):229-240.
Score: 0.227
-
Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials? Int J Infect Dis. 2020 Dec; 101:107-120.
Score: 0.226
-
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020 11; 14(11):1149-1163.
Score: 0.226
-
Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020 Dec; 20(6):571-590.
Score: 0.226
-
Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med. 2020 Aug - Sep; 170:106045.
Score: 0.221
-
Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures? Res Social Adm Pharm. 2021 02; 17(2):456-459.
Score: 0.220
-
Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea. Value Health Reg Issues. 2019 May; 18:18-23.
Score: 0.198
-
Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults. Expert Rev Pharmacoecon Outcomes Res. 2018 08; 18(4):371-377.
Score: 0.192
-
An Evaluation of the Central Nervous System Medication Use and Frailty among Residents of Aged Care Homes in Malaysia. Neuroepidemiology. 2017; 49(1-2):82-90.
Score: 0.183
-
Economic evaluation of pharmacist-led medication reviews in residential aged care facilities. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct; 17(5):431-439.
Score: 0.183
-
An evaluation of medication appropriateness and frailty among residents of aged care homes in Malaysia: A cross-sectional study. Medicine (Baltimore). 2017 Sep; 96(35):e7929.
Score: 0.183